Edaravone Improves Streptozotocin-Induced Memory Impairment via Alleviation of Behavioral Dysfunction, Oxidative Stress, Inflammation, and Histopathological Parameters
Alzheimer’s disease (AD), as the main cause of dementia, has a progressive and neurodegenerative pattern with number of cases increasing over the next decades. Therefore, discovering an effective treatment with the ability to invert memory impairment and pathophysiological events of AD seems to be r...
Saved in:
| Main Authors: | Mahdieh Anoush, Soroush Bijani, Fatemeh Moslemifar, Fatemeh Jahanpour, Ali Kalantari-Hesari, Mir-Jamal Hosseini |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Behavioural Neurology |
| Online Access: | http://dx.doi.org/10.1155/2023/9652513 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuroprotective effects of empagliflozin against scopolamine-induced memory impairment and oxidative stress in rats
by: Mahdieh Anoush, et al.
Published: (2025-06-01) -
Edaravone dexborneol compared to edaravone in the treatment of acute cerebral infarction: A meta-analysis
by: Yanshuo Shi, et al.
Published: (2025-06-01) -
Syringic Acid Attenuates Cardiomyopathy in Streptozotocin-Induced Diabetic Rats
by: Zahra Sabahi, et al.
Published: (2021-01-01) -
Edaravone's Safety Profile in Acute Ischemic Stroke
by: Laurence K. J. Batino, et al.
Published: (2024-12-01) -
The effect of Edaravone on clinical symptoms and oxidative stress factors in patients with acute ischemic stroke: A clinical trial
by: Mojtaba Khazaei, et al.
Published: (2024-04-01)